What Is the MOTS-C Sequence? A 16-Amino-Acid Breakdown

The MOTS-C sequence is a chain of 16 amino acids — MRWQEMGYIFYPRKLR — encoded in the mitochondrial 12S rRNA gene rather than in nuclear DNA. That short chain is what makes MOTS-C a mitochondrial-derived peptide and what separates it from an ordinary hormone. The exact order of those residues is also the benchmark researchers use to confirm that a sample labeled MOTS-C actually contains MOTS-C.

What the MOTS-C Sequence Actually Is

MOTS-C stands for Mitochondrial Open Reading Frame of the Twelve S rRNA type-c. It was described in 2015 by researchers at the University of Southern California, who reported that the peptide is translated from a short open reading frame inside the mitochondrial genome.

Three features define the molecule:

• Length: 16 amino acids, making it one of the smallest known peptide signaling molecules in mammals.
• Origin: mitochondrial DNA, specifically the MT-RNR1 region that also encodes 12S ribosomal RNA.
• Character: rich in arginine, tyrosine, and tryptophan, which leaves the peptide positively charged and gives it a distinctive mass fingerprint.

Any catalog listing for a mots-c peptide sequence should match that 16-residue chain letter for letter. A single substitution changes the molecular mass and usually signals that a supplier is selling a variant, a fragment, or an unrelated peptide.

The 16-Amino-Acid Sequence, Residue by Residue

Here is the human MOTS-C sequence written out in both one-letter and three-letter code.

Two methionines sit at positions 1 and 6, and four arginines give the peptide its strong positive charge. The chain starts with methionine and ends with arginine, a detail worth checking because the terminal form — free acid or amide — shifts the measured mass slightly.

Why the Sequence Matters: Identity, Purity, and Verification

Purity and identity are different things, and the sequence is the only way to check the second one. An HPLC trace showing 98% purity tells you how much of a sample sits under one peak. It does not tell you which peptide that peak is. Mass spectrometry does.

These sequence-level details are worth confirming on any certificate of analysis:

• Observed vs. theoretical mass: the two should agree within a fraction of a Dalton.
• Terminal form: free acid versus amide at the C-terminus, plus any N-terminal acetylation.
• Counter-ion: trifluoroacetate and acetate salts shift the number on a scale without changing the peptide.
• Tags and conjugates: biotin, FITC, or fluorescent labels add mass and change the sequence listing.

A certificate of analysis with mass spectrometry confirmation is the most reliable way to verify a peptide's sequence identity.

How MOTS-C Compares With Other Research Peptides

MOTS-C is often discussed alongside other mitochondrial and metabolic peptides, even though the molecules have little in common structurally.

Two peptides can both be 16 amino acids long and still be completely unrelated. AOD-9604 is a growth hormone fragment, while MOTS-C is a mitochondrial gene product, so comparing them residue by residue is not meaningful.

The most common comparison people search for is aod 9604 vs mots-c, and the honest answer is that the two share a length and almost nothing else. Online discussion about aod 9604 and mots-c together is not backed by published human trials.

What Research Suggests About MOTS-C

Most of what is known about MOTS-C comes from cell cultures and rodent models. In those systems the peptide influences how cells handle glucose and how mitochondria respond to metabolic stress.

• AMPK activation: MOTS-C has been reported to activate AMPK, a central energy-sensing enzyme, and to increase glucose uptake in muscle cells.
• Folate-methionine cycle: MOTS-C levels respond to methionine restriction, and the peptide appears to feed back on that pathway.
• Nuclear translocation: under metabolic stress, MOTS-C moves into the nucleus and influences antioxidant response genes.
• Age and exercise: circulating MOTS-C tends to decline with age, and some human studies report that it rises after a single bout of exercise.

Search interest in mots-c benefits is driven largely by that preclinical work. Human clinical trials remain very limited, and no regulatory agency has approved MOTS-C as a treatment for any condition.

It is worth noting what the sequence does not tell you. Knowing the 16 residues says nothing about potency, receptor targets, or how the peptide behaves in a living organism.

Safety, Sourcing, and Handling

MOTS-C is not FDA-approved for human use in the United States. Products sold online are labeled for laboratory research only, and there is no established human dose, safety profile, or long-term data.

Anyone considering a research peptide for personal use should talk with a licensed healthcare professional first. Unregulated peptides can carry risks from impurities, incorrect sequence identity, bacterial contamination, and endotoxins.

For laboratory work, standard handling practice includes:

1. Store lyophilized powder at -20°C or colder, protected from light.
2. Reconstitute with sterile or bacteriostatic water using gentle swirling rather than shaking.
3. Aliquot before freezing to avoid repeated freeze-thaw cycles.
4. Confirm identity by mass spectrometry and purity by HPLC on every new lot.

A peptide that matches the MOTS-C sequence on paper is only as good as the testing that confirms it in the vial.